MCRB
Seres Therapeutics, Inc.Company with tickers: MCRB
CIK
1609809
CUSIP
81750R201
Shares Outstanding
9,683,934
13F Activity (30d)
2 filings
1 filers
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Hans-Juergen Woerle, M.D., Ph.D. | member of the board of directors | Resigned | 2026-06-01 |